The Three Licensed Business Structures

Yes — foreign insurance companies can sell policies in China, but only through 3 licensed business structures: as a wholly foreign-owned insurance company (WFOIC), as a Sino-foreign joint venture insurance company, or as a foreign insurance company branch. Foreign participation in China’s insurance market is governed by the PRC Insurance Law (保险法, bǎoxiǎn fǎ, last amended 2015), the Administrative Regulations on Foreign-Invested Insurance Companies (外商投资保险公司管理条例, 2019 amendment), and the market-access provisions of the Foreign Investment Law (外商投资法, 2020). Since 2020, China has progressively relaxed ownership restrictions on foreign-invested insurance companies, eliminating the former 50% joint-venture requirement for life insurance and 51% requirement for non-life insurance. As of 2026, there are 68 foreign-invested insurance companies operating in China, holding approximately 7.8% of the total market premium according to the National Financial Regulatory Administration (NFRA), up from 5.2% in 2019.

The Three Licensed Business Structures

Foreign insurance companies seeking to sell policies in China must choose among three regulated entry structures, each with distinct capital requirements, business scope limitations, and regulatory obligations. The choice depends primarily on the foreign insurer’s global scale, risk appetite, and strategic objectives in the China market.

Wholly Foreign-Owned Insurance Company (WFOIC) — Since 2020, foreign investors have been permitted to establish wholly foreign-owned insurance companies without a Chinese partner. The minimum registered capital is RMB 200 million (PRC Insurance Law Article 73), which must be paid-in capital (实缴资本, shíjiǎo zīběn). WFOICs require a minimum of 30 years of continuous operation in the insurance business in their home jurisdiction and must have a representative office in China for at least 2 years before applying for a WFOIC license. As of 2026, Allianz (Germany), AIG (USA), Generali (Italy), AXA (France), Zurich (Switzerland), and Mapfre (Spain) are among the foreign insurers operating WFOICs in China.

Sino-Foreign Joint Venture Insurance Company — This structure involves a foreign insurer partnering with a Chinese domestic company. The 2020 regulatory reform eliminated the requirement for the foreign insurer to hold a maximum 50% stake in life insurance joint ventures, allowing foreign majority ownership. However, partner selection is critical — the Chinese partner must have a good business record and meet minimum asset thresholds set by the NFRA. Some well-known foreign insurers have maintained their existing JV structures (e.g., CITIC-Prudential, HSBC Life, Cigna & CMB Life) while others have exercised the option to increase their stake post-2020. The minimum registered capital for JVs is also RMB 200 million.

Foreign Insurance Company Branch — Non-life foreign insurers may establish a branch office in China without incorporating a separate Chinese entity. Branch structures are limited to non-life (property and casualty) insurance and face stricter business scope restrictions. Branches can only underwrite business that is directly related to foreign investment or foreign-invested enterprises, as specified under Article 6 of the Administrative Regulations on Foreign-Invested Insurance Companies. The branch model is most commonly used by smaller or regionally focused foreign insurers that want a limited China presence without the capital commitment of a WFOIC. The branch must maintain a minimum operating fund of RMB 200 million.

Licensing Requirements and Approval Process

The licensing process for a foreign insurance company to sell policies in China is administered by the National Financial Regulatory Administration (NFRA, 国家金融监督管理总局), which replaced the China Banking and Insurance Regulatory Commission (CBIRC) in March 2023. The application process involves a two-stage review, with a total processing time of 6 to 18 months depending on the complexity of the application and whether the NFRA requests supplementary materials. The overall approval rate for foreign insurance license applications has historically been moderate — approximately 60–70% of applications proceed to licensing, with common reasons for rejection including inadequate home-country regulatory oversight, insufficient capital adequacy, and concerns about the foreign insurer’s China market strategy.

Stage 1: Preliminary Approval (初审, chūshěn) — The foreign insurer submits a letter of intent, business plan, financial projections, and evidence of home-country qualification (30-year minimum operating history, home-country solvency margin compliance for the preceding 3 years, no major regulatory sanctions in the preceding 5 years). The NFRA reviews and, if satisfied, issues a preliminary approval letter (批准筹建, pīzhǔn chóujiàn). This stage typically takes 3–6 months. Upon receiving preliminary approval, the applicant has 1 year to complete the establishment preparations — including securing office premises (minimum floor area requirements by city), hiring qualified senior management (at least 3 senior executives with 5+ years of China insurance market experience each), and establishing internal control systems.

Stage 2: Final License Application (开业申请, kāiyè shēnqǐng) — After completing the preparatory phase, the applicant submits the final license application with evidence of capital injection (RMB 200 million paid-in), completed office fit-out, management team appointments, and operational readiness. The NFRA conducts an on-site inspection and, if satisfied, issues the insurance business license (保险公司法人许可证). This stage typically takes 3–6 months. The total process from initial application to license issuance averages 12–18 months. Once licensed, the insurance company must commence operations within 6 months of license issuance or the license may be revoked.

Business Scope Restrictions

Foreign-invested insurance companies are generally permitted to underwrite the same lines of business as domestic Chinese insurance companies, but with certain important restrictions. Life insurance companies — whether WFOIC or JV — may sell individual life, group life, accident, health, and investment-linked insurance products. Non-life insurance companies may sell property insurance, liability insurance, credit and guarantee insurance, marine and aviation insurance, and accident insurance. Since the 2020 market-access reforms, foreign insurers may also participate in mandatory insurance programs — including Jiao Qiang Xian (motor compulsory insurance) and certain government-subsidized agricultural insurance programs — though actual participation remains limited due to pricing and distribution challenges.

However, there are important restrictions that foreign insurers should be aware of. Foreign insurance company branches (the third structure) are limited to underwriting business directly related to foreign investment, including: insurance for foreign-invested enterprises in China, insurance for foreign companies’ projects in China, and reinsurance assumed from Chinese domestic insurers. Branches cannot sell personal lines insurance (private auto, homeowners, individual health, or individual life) to Chinese citizens. This restriction was historically a major barrier for branch-structure foreign insurers and has driven many to upgrade to WFOIC status. Additionally, foreign-invested insurers face limitations on RMB-denominated investment products and certain types of unit-linked or variable insurance products, which require NFRA approval for each product before sale.

Regulatory Compliance Obligations

Foreign insurance companies operating in China face comprehensive regulatory compliance obligations under the PRC Insurance Law and NFRA regulations. These include: maintaining minimum solvency ratios (solvency adequacy ratio ≥ 100% under the China Risk-Oriented Solvency System, C-ROSS Phase II implemented 2022); submitting quarterly and annual financial reports in Chinese to the NFRA; maintaining a designated compliance officer (合规负责人, hégui fùzérén) who is a Chinese citizen or permanent resident; implementing anti-money laundering (AML) procedures compliant with the PRC Anti-Money Laundering Law; and participating in the China Insurance Security Fund (保险保障基金, bǎoxiǎn bǎozhàng jījīn) contribution system, which requires insurers to contribute 0.05–0.8% of premium income to a systemic risk pool.

Foreign insurers must also comply with the PRC Personal Information Protection Law (PIPL, 个人信息保护法, 2021) when handling policyholder data, which imposes strict requirements on cross-border data transfer — a particularly significant issue for foreign insurers with global underwriting and claims systems. Under PIPL, transferring policyholder personal information outside China generally requires: a standard contractual clause filing with the Cyberspace Administration of China (CAC), a security assessment by the CAC for data volumes above 1 million individuals, or certification by a CAC-approved body. Foreign insurers with centralized global claims processing systems must ensure compliance with these requirements before accepting China-based policyholders.

Market Share and Competitive Position

As of 2026, foreign-invested insurance companies hold approximately 7.8% of China’s total insurance premium income, up from 5.2% in 2019 but still modest compared to the 20–30% market share foreign insurers hold in many other Asian markets. Foreign insurers are more competitive in specific segments: in reinsurance, foreign companies (including Munich Re, Swiss Re, Hannover Re, and SCOR) hold approximately 25% of the inwards reinsurance market; in high-net-worth life insurance, foreign insurers hold an estimated 30–40% of the market; and in international cargo and marine insurance, foreign insurers underwrite approximately 20% of premium volume. The overall market share is constrained by the limited branch network of foreign insurers — the top 5 Chinese domestic insurers have combined agency workforces of over 8 million agents, while the entire foreign-invested insurance sector employs fewer than 50,000 agents across all companies.

The outlook for foreign insurance company growth in China is cautiously positive. The 2025–2026 NFRA Financial Opening Action Plan (金融开放行动计划) includes commitments to: further streamline the licensing process for foreign insurers (target: reduce to 9 months), expand the scope of business permitted to foreign-invested insurance companies (including broader participation in government-subsidized health insurance programs), and relax the 30-year operating history requirement for insurers from countries with equivalent regulatory frameworks. These changes are expected to gradually increase foreign insurers’ market share to 10–12% by 2030, though significant competitive barriers — including branch network limitations, digital distribution dominance by domestic players (WeChat/Alipay insurance platforms), and the high cost of establishing a nationwide presence — will continue to constrain growth.

Market Entry Assessment Checklist

Before applying for an insurance license in China, complete this checklist:

1. Confirm home-country eligibility — Your company must have at least 30 years of continuous insurance operations in its home jurisdiction. Prepare audited financial statements demonstrating solvency compliance for the preceding 3 years.
2. Establish a representative office — Maintain a representative office in China for at least 2 years before applying for a WFOIC license. The representative office must demonstrate genuine business development activity, not merely passive presence.
3. Select the right entry structure — For full market access (all insurance lines), apply for a WFOIC or JV with a minimum registered capital of RMB 200 million. For limited non-life business only, consider the branch structure (also requires RMB 200 million operating fund).
4. Prepare capital injection documentation — Demonstrate that the RMB 200 million paid-in capital is sourced from legitimate, non-borrowed funds. Capital verification (验资报告, yànzī bàogào) must be conducted by a PRC-licensed CPA firm.
5. Recruit qualified senior management — Hire at least 3 senior executives with 5+ years of China insurance market experience each. Key positions: General Manager, Chief Actuary, Compliance Officer. All must pass NFRA fitness and propriety review.
6. Establish local office and systems — Secure office premises meeting NFRA minimum floor-area requirements. Implement C-ROSS Phase II compliant risk management systems. Establish AML/KYC procedures compliant with PRC Anti-Money Laundering Law.
7. Submit final license application — File the complete application dossier with the NFRA. The final approval stage takes 3–6 months including an on-site inspection. Once licensed, commence operations within 6 months or the license may be revoked.

Where to Go From Here

Based on what you just read:

• Ready to act? Read [guide: SLUG-TO-BE-FILLED]
• Still comparing? See [comparison: SLUG-TO-BE-FILLED]
• Need numbers? Try [tool: SLUG-TO-BE-FILLED]

Can foreign insurance companies sell policies in China? — first published on China Gateway 360. Last updated: July 2026.